Electrical cardioversion for atrial fibrillation and flutter

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 11, 2017, Pages

  Mead, Gillian E ^a   Elder, Andrew ^b   Flapan, Andrew D ^c   Cordina, John ^d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Royal Victoria Hospital Edinburgh   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULATION; ATRIAL FIBRILLATION; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; HEART ATRIUM FLUTTER; HEART RATE; HEART RHYTHM; HOSPITAL READMISSION; HUMAN; MENTAL DETERIORATION; MORTALITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; THERAPY EFFECT; THROMBOEMBOLISM; ADULT; META ANALYSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; ATRIAL FIBRILLATION; ATRIAL FLUTTER; ELECTRIC COUNTERSHOCK; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85034015555     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002903.pub3     Document Type: Review

References (33)

1. Opoloski G Torbicki A Kosier D Stolarz P Dawidowska R Zawadzka M, et al. Should we restore sinus rhythm in patients with chronic atrial fibrillation? Hot Cafe pilot study. Polskie Archiwum Medycyny Wewnetrznej 1999;5:413-18. 3123709
2. Opoloski G, Torbicki A, Kosior DA, Szulc M, Wozakowska-Kapton B. Koloziej P Achremczyk P for the Investigators of the Polish Hot Cafe Trial. The results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest 2004;126:476-486. 3123710
3. Hagens VE, Ranchor AV, van Sonderen E, Bosker HA, Kamp O, Tijssen JGP, et al. Effect of rate control or rhythm control on quality of life in persistent atrial fibrillation. J Am Coll Cardiol 2004;43:241-7. 3123712
4. van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al. A comparison of rate control and rhythm control in patients with recurrent and persistent atrial fibrillation. N Eng J Med 2002;347:1834-40. 3123713
5. Carlsson J Miketic S Windeler J Cuneo A Haun S Micus S Walter S Tebbe U. Randomised trial of Rate-Control Versus Rhythm Control in Persistent Atrial Fibrillation. The Strategies of Treatment of Atrial Fibrillation (STAF) Study. J Am Coll Cardiol 2003;41:1690-6. 3123715
6. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrrial fibrillation. N Eng J Med 2002;347(1825-33). 3123717
7. Gosselink ATM, Crijns HJGM, van den Berg MP, van den Broek SAJ, Hillege H Landsman MLJ Lie KI. Functional capacity before and after cardioversion of atrial fibrillation: a controlled study. Br Heart J 1994;72:161-166. 3123719
8. Hohnloser SH Kuck K-H Lilienthal J for the PIAF investigators. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000;356:1789-94. 3123721
9. Vora A, Karnad D, Goyal V, Naik A, Gupta A, Lokhandwala Y, Kulkarni H, Singh B. Control of Rate versus Rhythm in Rheumatic Atrial Fibrillation: A Randomized Study. Indian Heart J 2004;56:110-116. 3123723
10. Yamashita T Ogawa S Aizawa Y et al on behalf of the J-RHYTHM Investigators. Investigation of the Optimal Treatment Strategy for Atrial Fibrillation in Japan. The J-RHYTHM (Japanese Management Trial for Atrial Fibrillation) Study Design. Circ J 2003;67:738-741. 3123725
11. The AFFIRM Investigators. Relationship between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004;109:1509-1513.
12. Alam M, Thorstrand C. Left ventricular function in patients with atrial fibrillation before and after cardioversion. Am J cardiol 1992;69:694-6.
13. Benavente O, Hart R, Koudstaal P, Laupacis A, McBride R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischaemic attacks. Cochrane Library, Oxford, Update Software 2000, (1). [ISSN 1464-780X]
14. Benavente O, Hart R Koudstaal P, Laupacis A, McBride R. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks (Cochrane Review). Cochrane Library. Oxford: Update Software 2000, (1). [ISSN 1464-780X]
15. Shelton RJ, Kaye GC, Cleland JGF. Controlling persistent atrial fibrillation. Q J Med 2004;97:179-180.
16. Cordina J Mead G. Pharmacological cardioversion for atrial fibrillation/flutter. Cochrane Library 2002, Issue 2.
17. Cordina J, Mead G. Pharmacological cardioversion for atrial fibrillation and flutter. The Cochrane Database of Systematic Reviews 2005;Issue 2.
18. Dickersin K, Scherer R, Lefebve C. Identifying relevant studies for systematic reviews. BMJ 1994;309:1286-91.
19. Hampton JR. How do we restore sinus rhythm in persistent atrial fibrillation?. Proceedings of the Royal College of Physicians of Edinburgh. 1999; Vol. 29 (supplement 6):13.
20. Kilander L, Andren B, Nyman H, Lind L, Boberg M, Lithell H. Atrial fibrillation is an independent determinant of low cognitive function A cross-sectional study in elderly men. Stroke 1998;29:1816-20.
21. Laupacis A Albers G Dalen J, et al. Antithrombotic treatment in atrial fibrillation. Chest 1998;114:579-89S.
22. Lip GYH. Cardioversion of atrial fibrillation. Postgrad Med J 1995;71:457-65.
23. Mancini GBJ Goldberger AF. Cardioversion of atrial fibrillation: consideration of embolisation, anticoagulation, prophylactic pacemaker and long-term success. Am Heart J 1992;104:617-21.
24. Moher D Schulz KF Altman D for the CONSORT group. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials. JAMA 2001;285(15):1987-1991.
25. Ott A, Breteler MB, de Bruyne MC, van Harksamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population based study. The Rotterdam Study. Stroke 1997;28:316-21.
26. Roy D. (AF-CHF) Atrial fibrillation and congestive heart failure. Project protocol, Montreal Heart Institute, Quebec, Canada December 2000.
27. Schamroth L. An Introduction to Electrocardiography. 7. Oxford: Blackwell Scientific Publications, 1990.
28. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation in and eligibility of anticoagulants in the community. Lancet 1998;352:1167-71.
29. Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991;68:41-6.
30. Van Gelder IC, Crijns HJ, Blanksma PK, et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J cardiol 1993;72:560-6.
31. Verheugt FWA van Gelder IC Wyse DG Hohnloser S Carlsson J Crijns HJ. Paradoxical increase in Strokes in the randomised trials of rate control versus rhythm control in atrial fibrillation. Journal of American College of Cardiology. 2003; Vol. 41:130A.
32. Ware JE, Jr. SF36 Health Survey, Manual Interpretation Guide. Boston MA: The Health Institute, New England Medical Centre, 1993.
33. Xiong C, Sonnhag C, Nylander E, Wranne B. Atrial and ventricular function after cardioversion of atrial fibrillation. Br Heart J 1995;74:254-60.